What Is the Vagus Nerve? What the Evidence Shows

The vagus nerve is the longest cranial nerve, a left and right pair that carries signals between the brainstem and the heart, lungs, voice box and gut¹. Surgeons can stimulate it with an implanted device for drug-resistant epilepsy and treatment-resistant depression^{1, 2}. Online "resets" lack comparable trial data², though slow breathing raises a heart-rate marker of vagal activity³.

Most of what people want to do with this nerve, such as calming anxiety or easing digestion, belongs on our evidence pages for anxiety and digestive health. This guide explains the nerve itself and how far the research goes.

The vagus nerve, or cranial nerve X, is the longest cranial nerve and carries both sensory and motor fibers¹. "Vagus" is Latin for "wandering", because the nerve branches out to the heart, lungs, spleen, liver, diaphragm and intestines².

Its fibers do four main jobs¹:

• Swallowing and voice: fibers from the nucleus ambiguus control the muscles of the pharynx and larynx.
• Heart and lungs: fibers from the dorsal motor nucleus give involuntary motor control to the heart, lungs and esophagus.
• Gut: the same nucleus supplies glands throughout the gastrointestinal tract.
• Reporting back: sensory fibers send information from the organs to the brainstem, and the nerve also carries taste from the pharynx.

In plain terms, the brain asks the heart, lungs and gut how they are doing, and the answers mostly come back through this nerve². Much of the detailed mapping comes from rats, so some human anatomy is still incompletely known².

The vagus nerve starts in the medulla of the brainstem and leaves the skull through the jugular foramen¹. In the neck it runs inside the carotid sheath, between the carotid artery and the internal jugular vein¹. To trace it, touch the lower part of your ear (the lobule) and walk your fingers down the side of your neck².

The neck section gives off four branches: pharyngeal, superior laryngeal, recurrent laryngeal and superior cardiac¹. Below the neck, the left and right nerves pass the lungs and join around the esophagus before reaching the stomach and abdomen¹.

Vagus nerve problems can show up in many ways, because the nerve reaches so many organs¹. On examination, clinicians look for these signs of damage to the nerve or its branches¹:

• Hoarseness: when the gag reflex and palate movement are normal, it points to the recurrent laryngeal nerve, the branch that works most of the voice box muscles.
• Trouble swallowing or slurred speech: seen when the damage is in the brainstem, where the nerve starts, including one type of stroke (lateral medullary syndrome).
• A uvula that tilts away from the affected side: found when someone says "ah" during an exam.

Damage can also slow digestion. Diabetes, the most common known cause of gastroparesis (slow stomach emptying), can damage the vagus nerve, and so can surgery on the esophagus, stomach or small intestine. Symptoms include feeling full soon after starting a meal, nausea, vomiting and bloating⁴. The recurrent laryngeal nerve can also be injured during thyroid surgery and some esophageal operations¹.

What kind of doctor should I see?

Sudden slurred speech, a drooping face or a weak arm needs emergency care: these are stroke warning signs, so call emergency services straight away, even if they pass⁵.

For other symptoms, start with a primary care clinician, who can examine you and refer you to an ear, nose and throat (ENT) specialist if needed. Hoarseness that has not improved within 4 weeks should be checked with laryngoscopy, a direct look at the voice box, and sooner if a serious cause is suspected⁶. Our pages on palpitations and acid reflux cover other causes.

The vagus nerve slows the heart. Its superior cardiac branch carries parasympathetic fibers that adjust heart rate and conduction¹. It also supplies the lungs through bronchial branches and controls the airway reflexes of the larynx¹.

Stimulating the larynx can trigger coughing and a pause in breathing (apnea), along with a slower heart rate and lower blood pressure¹. Cough and breathlessness are reported side effects of implanted stimulators^{7, 8}.

The same braking effect is behind the most common type of fainting in adults, vasovagal syncope. Pain, emotional upset or often no clear trigger sets off a burst of vagal activity that slows the heart, while blood vessels relax and blood pressure falls⁹. A faint should still be checked by a doctor, and it needs emergency care if it happens during exercise or while lying down, or comes with chest pain or a pounding or irregular heartbeat¹⁰.

Researchers estimate vagal activity to the heart indirectly with heart rate variability (HRV), the beat-to-beat change in heart rhythm³. Our heart rate variability page lists the supplements studied for it.

A "vagus nerve reset" is a wellness-media term for eye movements, humming, massage, cold-water immersion or meditation said to calm the nervous system². An article on these claims from McGill University's Office for Science and Society calls them unsubstantiated: if they help, it is probably through relaxation rather than any special effect on the nerve².

McGill's article says eye-movement exercises need to show their worth before anyone calls them effective². Our search found no trial of a named routine, pressure point or neck-decompression technique either.

Cold-water immersion is not a gentle reset. Sudden cold sets off a cold shock reflex of uncontrolled fast breathing that makes heart rhythm problems and drowning more likely¹¹. When the head goes under, the clash between cold shock and the vagus-driven diving reflex can disturb heart rhythm even in healthy volunteers¹².

Which side should I sleep on for the vagus nerve?

The research is small and conflicting. A study of healthy volunteers found the highest vagal marker (normalised high-frequency power) lying on the right side, then left, then back¹³. In 58 healthy young adults, left-side lying lowered heart rate but did not change any heart rate variability measure¹⁴. Neither study measured sleep, so pick the side that lets you sleep well.

It raises a heart rate marker of vagal activity, which makes slow breathing the best-supported method you can do yourself. A 2022 meta-analysis of 223 studies found that voluntary slow breathing increased vagally mediated HRV during the session, right after it and after multi-session programmes³. The authors judged it a low-cost technique with few adverse effects expected³.

Two limits matter. HRV is a marker, not a health outcome, so a higher number does not by itself show you feel better. And any benefit may owe more to simple relaxation than to the nerve: McGill's article notes that pausing to focus on your breathing can help for a while². For stress and mood goals, see our stress management hub.

Yes, for one specific rhythm problem. In the REVERT trial, 433 adults in English emergency departments with supraventricular tachycardia (excluding atrial fibrillation and flutter) strained against 40 mm Hg for 15 seconds¹⁵. One minute later, a normal (sinus) rhythm had returned in 17% (37 of 214) after the standard maneuver and 43% (93 of 214) after the modified version, which adds lying flat with the legs raised straight after the strain (odds ratio 3.7, 95% CI 2.3 to 5.8)¹⁵. No serious adverse events were recorded¹⁵.

Doctors can also massage the carotid sinus in the neck to slow an irregular rhythm through the vagus nerve². This is a clinical procedure. Do not press on your neck yourself.

Implanted vagus nerve stimulation (VNS) places a generator under the skin of the chest and connects a lead to the left vagus nerve¹. The left nerve is used more often because the right one is more likely to carry branches to the heart¹. In the US, the FDA has approved implanted vagus nerve stimulators for these uses:

• Drug-resistant epilepsy: an add-on treatment for people aged 4 and older with focal (partial-onset) seizures that medicines have not controlled¹⁶. A 2022 ILAE meta-analysis of 30 studies of three implanted stimulation methods (6 randomized) found a pooled mean seizure reduction of 34.7% in five observational VNS studies at about 1.3 years, with a confidence interval so wide (-5.1 to 74.5) that it includes no effect. Hoarseness, cough and throat pain were the common complications⁷. Our epilepsy page covers the wider picture.
• Treatment-resistant depression: approved in 2005 as a long-term add-on for adults in a major depressive episode who have not responded to four or more adequate antidepressant treatments¹⁷. In a 10-week sham-controlled trial of 235 outpatients, 15.2% responded with active VNS and 10.0% with sham, a difference that was not statistically significant (p = 0.251)¹⁸. In a 12-month trial of 493 adults, the main outcome did not separate active from sham, though several secondary ratings favoured active VNS⁸. See depression.
• Arm weakness after a stroke: a different implant, approved in 2021, stimulates the nerve during rehabilitation exercises in people with moderate to severe arm weakness that persists long after an ischemic stroke¹⁹. In its pivotal trial of 108 people, an arm impairment score rose 5.0 points with active stimulation and 2.4 points with sham after 6 weeks of therapy²⁰. See stroke recovery.
• Rheumatoid arthritis: another implant, approved in 2025, treats adults with moderate to severe disease after one or more biologic or targeted synthetic drugs failed or were not tolerated²¹. In its pivotal trial of 242 patients, 35.2% reached a standard 20% improvement score (ACR20) at 3 months with active stimulation, against 24.2% with sham²². See rheumatoid arthritis.

Each option needs surgery. The trial gains above are modest, and for depression the results are mixed. These are specialist options for people whom standard treatment has not helped enough.

Non-invasive stimulators act through the skin, with no surgery². The ear-based type is called transcutaneous auricular VNS (taVNS), and its evidence is early.

• Depression: a meta-analysis of 12 randomized trials in 838 people found that taVNS lowered depression scores and gave higher response rates than sham, but the evidence was rated low to very low quality²³.
• Functional dyspepsia: in a 300-patient trial, 4 weeks of taVNS gave response rates of 81.2% (10 Hz) and 75.9% (25 Hz) against 47% with sham²⁴.
• Safety: a review of 177 studies and 6,322 people found no higher adverse-event risk than controls, with ear pain, headache and tingling most often reported, though 55% of the studies did not say whether any side effects occurred²⁵.

In the US, the FDA has cleared a handheld stimulator, held against the side of the neck and used on prescription, to prevent and treat migraine from age 12²⁶. In adults it is also cleared to treat episodic cluster headache attacks, help prevent cluster headache and treat two rarer headache disorders²⁶. McGill's article adds that non-invasive devices are cleared in some countries for other problems too, but that evidence on how they should be used is not always optimal².

It is one of the links. The nerve supplies the gut and sends sensory information from it to the brainstem¹, and it helps the brain sense pressure, pain, temperature and inflammation in the body². The dyspepsia trial above suggests that stimulating its ear branch can ease symptoms in some adults²⁴.

That does not make every digestive complaint a vagus problem. McGill calls the "everything wrong with you is the vagus nerve" story a myth². For the supplement side of the gut-brain connection, see our gut-brain axis support page and the guide to digestive health supplements.

Match the action to the goal:

• Sudden slurred speech, a drooping face or a weak arm: call emergency services straight away, even if it passes. These are stroke warning signs⁵.
• Hoarseness that has not improved within 4 weeks, or trouble swallowing: see a clinician for a throat and vocal cord exam⁶.
• Racing heartbeat, fainting or chest pain: seek medical care, and call emergency services if you faint during exercise or while lying down, or faint with chest pain or a pounding heartbeat¹⁰. Vagal maneuvers are for diagnosed, stable rhythms under guidance.
• Drug-resistant epilepsy, hard-to-treat depression, arm weakness after a stroke, or rheumatoid arthritis that advanced drugs have not controlled: ask a specialist whether an implanted stimulator fits your history.
• General stress: slow breathing has the best trial support of the home methods, with few side effects expected³.
• Eye movements and humming: treat them as relaxation, not a nerve reset².
• Cold plunges: not a gentle reset. Cold shock makes heart rhythm problems and drowning more likely, so check with a doctor first if you have a heart condition^{11, 12}.

Supplements in this guide

• Magnesium
• Omega-3 Fatty Acids
• Ashwagandha

On 14 October 2026 we searched PubMed-indexed literature for vagus nerve stimulation, slow breathing and heart rate variability, vagal maneuvers for supraventricular tachycardia, transcutaneous auricular stimulation and sleeping position. We read the abstracts of 10 journal papers, mostly systematic reviews and randomized trials, plus a StatPearls anatomy chapter and a McGill University Office for Science and Society article on vagus nerve claims. The same day, an independent review checked every claim against its source, and we corrected the article, adding FDA records for each device we describe, two pivotal device trials, a hoarseness guideline, two reviews on cold-water immersion, and NHS, NIH and StatPearls pages on stroke, fainting and gastroparesis. All 26 sources are cited, and the 15 journal papers were read at abstract level only. Human anatomy is partly mapped from animal work, and we found no trials of the popular home "reset" exercises, so we report that gap instead of filling it.

1. Kenny BJ, Bordoni B. Neuroanatomy, Cranial Nerve 10 (Vagus Nerve). In: StatPearls. Treasure Island (FL): StatPearls Publishing; updated 7 November 2022. https://www.ncbi.nlm.nih.gov/sites/books/NBK537171/
2. Jarry J. Resetting the Hype Around the Vagus Nerve. McGill University Office for Science and Society; 13 May 2022. https://www.mcgill.ca/oss/article/critical-thinking/resetting-hype-around-vagus-nerve
3. Laborde S, et al. Effects of voluntary slow breathing on heart rate and heart rate variability: A systematic review and a meta-analysis. Neurosci Biobehav Rev. 2022;138:104711. doi:10.1016/j.neubiorev.2022.104711
4. National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of Gastroparesis. Last reviewed January 2018. https://www.niddk.nih.gov/health-information/digestive-diseases/gastroparesis/symptoms-causes
5. NHS. Symptoms of a stroke. Page last reviewed 12 September 2024. https://www.nhs.uk/conditions/stroke/symptoms/
6. Stachler RJ, et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update). Otolaryngol Head Neck Surg. 2018;158(1_suppl):S1-S42. doi:10.1177/0194599817751030
7. Touma L, et al. Neurostimulation in people with drug-resistant epilepsy: Systematic review and meta-analysis from the ILAE Surgical Therapies Commission. Epilepsia. 2022;63(6):1314-1329. doi:10.1111/epi.17243
8. Conway CR, et al. Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial. Brain Stimul. 2025;18(3):676-689. doi:10.1016/j.brs.2024.12.1191
9. Jeanmonod R, Sahni D, Silberman M. Vasovagal Episode. In: StatPearls. Treasure Island (FL): StatPearls Publishing; updated 17 July 2023. https://www.ncbi.nlm.nih.gov/sites/books/NBK470277/
10. NHS. Fainting. Page last reviewed 17 August 2026. https://www.nhs.uk/symptoms/fainting/
11. Barwood MJ, et al. Habituation of the cold shock response: A systematic review and meta-analysis. J Therm Biol. 2024;119:103775. doi:10.1016/j.jtherbio.2023.103775
12. Shattock MJ, et al. 'Autonomic conflict': a different way to die during cold water immersion? J Physiol. 2012;590(14):3219-30. doi:10.1113/jphysiol.2012.229864
13. Chen GY, et al. The effect of the lateral decubitus position on vagal tone. Anaesthesia. 1997;52(7):653-7. doi:10.1111/j.1365-2044.1997.114-az0106.x
14. Sasaki K, et al. Left Recumbent Position Decreases Heart Rate without Alterations in Cardiac Autonomic Nervous System Activity in Healthy Young Adults. Tohoku J Exp Med. 2017;241(4):309-318. doi:10.1620/tjem.241.309
15. Appelboam A, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet. 2015;386(10005):1747-53. doi:10.1016/S0140-6736(15)61485-4
16. US Food and Drug Administration. Premarket Approval P970003/S207: stimulator, autonomic nerve, implanted for epilepsy (indication for patients 4 years of age and older). Decision date 23 June 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P970003S207
17. US Food and Drug Administration. Premarket Approval P970003/S050: stimulator, autonomic nerve, implanted (depression). Decision date 15 July 2005. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p970003s050
18. Rush AJ, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005;58(5):347-54. doi:10.1016/j.biopsych.2005.05.025
19. US Food and Drug Administration. Premarket Approval P210007: stimulator, autonomic nerve, implanted for stroke rehabilitation. Decision date 27 August 2021. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P210007
20. Dawson J, et al. Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. Lancet. 2021;397(10284):1545-1553. doi:10.1016/S0140-6736(21)00475-X
21. US Food and Drug Administration. Premarket Approval P240039: vagus nerve stimulator for rheumatoid arthritis. Decision date 30 July 2025. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P240039
22. Tesser JRP, et al. Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial. Nat Med. 2026;32(1):369-378. doi:10.1038/s41591-025-04114-7
23. Tan C, et al. The efficacy and safety of transcutaneous auricular vagus nerve stimulation in the treatment of depressive disorder: A systematic review and meta-analysis of randomized controlled trials. J Affect Disord. 2023;337:37-49. doi:10.1016/j.jad.2023.05.048
24. Shi X, et al. Transcutaneous Auricular Vagal Nerve Stimulation Is Effective for the Treatment of Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Am J Gastroenterol. 2024;119(3):521-531. doi:10.14309/ajg.0000000000002548
25. Kim AY, et al. Safety of transcutaneous auricular vagus nerve stimulation (taVNS): a systematic review and meta-analysis. Sci Rep. 2022;12(1):22055. doi:10.1038/s41598-022-25864-1
26. US Food and Drug Administration. 510(k) K211856: external vagal nerve stimulator for headache, clearance letter and indications for use. 10 September 2021. https://www.accessdata.fda.gov/cdrh_docs/pdf21/K211856.pdf